For Companies and Institutions
Key Links
For Institutional Investors
Putting our long-tenured investment teams on the line to earn the trust of institutional investors.
Direct access to market leading liquidity harnessed through world-class research, tools, data, and analytics.
Helping institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of a rapidly evolving market.
Leveraging cutting-edge technology and innovative tools to bring clients industry-leading analysis and investment advice.
Helping hedge funds, asset managers and institutional investors meet the demands of a rapidly evolving market.
Global short-term fixed income strategies designed to help clients manage liquidity through the cycle.
Key Links
For Individuals
For Employers
Enhance your equity compensation offering with solutions designed to empower your employees and bring your reward strategy to life.
Key Links
Who We Serve
Key Links
Explore a variety of insights.
Key Links
Insights by Topic
Explore a variety of insights organized by different topics.
Key Links
Insights by Type
Explore a variety of insights organized by different types of content and media.
Key Links
We aim to be the most respected financial services firm in the world, serving corporations and individuals in more than 100 countries.
Key Links
Effective and safe therapies for neurological diseases are practically nonexistent. Montara is changing that. J.P. Morgan's expertise in life sciences drew us to them as the obvious choice for Montara Therapeutics. Early in the company's history, we had this really critical inflection point. And the J.P. Morgan team gave us the security and support to allow us to focus on the science. Working with J.P. Morgan provided us with the clarity to move from early science to a scalable platform. It could help us make a real difference in patients' lives.
Montara Therapeutics is developing more effective therapies for neurological diseases to improve patient outcomes. The team sought secure, expert business support—so they could focus on the science that drives progress in medicine.
Working with J.P. Morgan, Montara Therapeutics gained the strategic support to build a platform that delivers safer, more effective therapies for people with neurological diseases.
“Working with J.P. Morgan provided us with the clarity to move from early science to a scalable platform. It could help us make a real difference in patients' lives.”
—Nicholas Hertz, Founder and CEO, Montara
Whether you’re building a life sciences startup or preparing for public launch, we can help you reach your next milestone. Connect with J.P. Morgan Startup Banking today, and explore our Innovation Economy content hub for more insights.
JPMorgan Chase Bank, N.A. Member FDIC. Visit jpmorgan.com/commercial-banking/legal-disclaimer for disclosures and disclaimers related to this content.
8:13 - Banking
The new defense playbook: Partnerships, capital, capability
Aug 06, 2026
Modern defense readiness depends on faster innovation, more resilient supply chains and closer coordination across government, industry and capital providers.
10:30 - Banking
The capital required for critical supply chains
Aug 05, 2026
Economic security and resiliency depends on diversifying supply chains and building industrial capacity to reduce vulnerabilities and avoid bottlenecks. In this video, experts from the Security and Resiliency Initiative weigh in on the future of the global supply chain.
1:55 - Banking
The KnectIQ story: From infinity problem to founder solution
Aug 04, 2026
Ken Morris shares how KnectIQ is eliminating vulnerabilities in cybersecurity, protecting investors and scaling with support from J.P. Morgan.
Banking
Powering Fervo’s journey in next-generation geothermal
Jul 27, 2026
Fervo Energy’s breakthrough in geothermal points to a new era of around-the-clock power and grid reliability.
Banking
Private credit for startups: core factors and trade-offs
Jul 24, 2026
Flexible private credit solutions can help startups access capital outside traditional banks, but may involve higher costs and unique risks.
Banking
Powering for Growth: APAC CFO & Treasurers Forum
The annual forum brings together insightful perspectives and peer-to-peer exchanges on the macro forces and trends shaping opportunities ahead.
1:17 - Banking
Copa Airlines CFO: Our relationship with J.P. Morgan is "more than transactional"
Jul 20, 2026
Hear how J.P. Morgan connected Copa Airlines CFO Peter Donkersloot to the help his company needed to weather turbulent energy markets and stay focused on long-term priorities.
2:27 - Banking
Data decoded: Aily Labs is building the decision intelligence operating system for the Fortune 500
Jul 16, 2026
Aily Labs is building the decision intelligence operating system for the Fortune 500
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.